Emma M. Lees
机构:Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (Belgium) · ORCID:0000-0001-7738-1399
发表论文 250 篇 · 总被引 15616 次 · h-index 55
代表论文
- DGKα/ζ inhibitors combine with PD-1 checkpoint therapy to promote T cell–mediated antitumor immunity (2023 · Science Translational Medicine · 被引 31)
- 12. Town and country planning (2024 · Oxford University Press eBooks · 被引 26)
- Discovery and Synthesis of Heterobifunctional Degraders of Rearranged during Transfection (RET) Kinase (2024 · Journal of Medicinal Chemistry · 被引 9)
- Restoring the Regulated: The EU’s Nature Restoration Law (2025 · Journal of Environmental Law · 被引 6)
- Performative Environmental Law (2024 · Modern Law Review · 被引 5)
- Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C (2026 · Nature Communications · 被引 4)